Purchase Order 75D30124P19350
- Not listed
- The U.S. Centers for Disease Control and Prevention (CDC) has awarded a Firm Fixed Price Delivery Order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $130,151.30, is to provide the Roche Cobas R 4800 and Cobas R 6800 systems and associated reagents, which are validated, PEPFAR approved, WHO prequalified, and FDA approved for HIV viral load and early infant diagnosis...
- The Centers for Disease Control and Prevention (CDC) awarded a sole-source, firm-fixed-price purchase order to Roche Diagnostics Corporation to provide biomedical reagents, testing supplies, and commodities required to conduct HIV molecular laboratory testing. The $25,725.24 contract has an ultimate completion date of October 17, 2029. The requirement is not set aside, as Roche Diagnostics is identified as the only vendor capable of providing the proprietary reagents and supplies compatible with...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for the maintenance of COBAS4800 and COBAS6800 equipment, with a total ceiling value of $130,151.30. The award was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian federal agency. The contract is a Delivery Order with a Firm Fixed Price...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at $29,600.00, is for the supply of ROCHE COBAS 5800 REAGENTS under a firm fixed-price purchase order. The contract has an ultimate completion date of June 1, 2024. Roche Diagnostics...
- This is a $169,474.83 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which has a period of performance through March 31, 2027, is not designated as a set-aside. Roche Diagnostics holds multiple significant Indefinite Delivery Vehicles (IDVs) and Blanket...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $113,563 contract provides ICF laboratory equipment and maintenance for the CDC's Pittsburgh location. This award is not designated as a set-aside. Roche Diagnostics has received numerous federal contract awards from agencies including the Department...
- The Centers for Disease Control and Prevention (CDC) awarded a $93,496 purchase order to Roche Diagnostics Corporation for the delivery of Roche COBAS C6800/AMPLIPREP/CAPTAQ systems. This firm fixed price contract will provide the CDC's Pittsburgh location with laboratory equipment and supplies to support its disease testing and prevention efforts. Roche will deliver the requested products to the CDC site in Castleton, Indiana by October 25, 2023. No subcontractors or set aside designations were...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $108,800.00, is for preventative maintenance services to be performed by March 31, 2028. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $165,500 firm fixed price purchase order to Roche Diagnostics Corporation. Under this contract, Roche will provide ROCHE COBAS 5800 laboratory equipment to the CDC in Castleton, Indiana by mid-November 2023. The CDC is a leading public health agency, and this equipment will likely support its efforts to advance health equity and combat infectious diseases through laboratory testing and...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products and laboratory equipment. The contract, valued at $71,530.00, is for a ROCHE COBAS 5800 CLASSIC SERVICE PLAN to provide maintenance and support services for this medical diagnostic instrument used by the CDC laboratory in Atlanta, Georgia. The contract does not have a set-aside...
Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $572,044.24 by the Centers for Disease Control and Prevention (CDC) Pittsburgh for maintenance services on COBAS HIV equipment with operations support. The contract, awarded on July 17, 2024, carries an ultimate completion date of September 4, 2028, and will be performed in Castleton, Indiana. This award represents a non-competitive procurement with no set-aside designation, reflecting Roche's established relationship as a provider of diagnostic solutions to federal healthcare agencies. The maintenance contract supports the CDC's laboratory testing infrastructure, enabling continued operational capability of the COBAS HIV testing systems used in disease surveillance and diagnostic applications. Roche Diagnostics Corporation, a subsidiary of Swiss-based Roche and a global leader in in vitro diagnostic equipment and reagents, regularly provides similar maintenance and supply services across multiple federal agencies including the Department of Veterans Affairs and the Defense Health Agency. This procurement falls within the company's broader portfolio of federal contracts related to molecular diagnostics and laboratory instrument support, which collectively demonstrate Roche's significant presence in the federal diagnostic testing market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $142.5k | 9/2/25 | |
| Not listed | Not listed | $144.5k | 7/17/24 |